PL358886A1 - Związki do leczenia upośledzonego wiotczenia dna żołądka - Google Patents

Związki do leczenia upośledzonego wiotczenia dna żołądka

Info

Publication number
PL358886A1
PL358886A1 PL01358886A PL35888601A PL358886A1 PL 358886 A1 PL358886 A1 PL 358886A1 PL 01358886 A PL01358886 A PL 01358886A PL 35888601 A PL35888601 A PL 35888601A PL 358886 A1 PL358886 A1 PL 358886A1
Authority
PL
Poland
Prior art keywords
sup
sub
alkyl
bivalent radical
alk
Prior art date
Application number
PL01358886A
Other languages
English (en)
Other versions
PL201656B1 (pl
Inventor
Emelen Kristof Van
Bruyn Marcel Frans Leopold De
Manuel Jesus Alcazar-Vaca
Jose Ignacio Andres-Gil
Francisco Javier Fernandez-Gadea
Maria Encarnacion Matesanz-Ballesteros
Jose Manuel Bartolome-Nebreda
Original Assignee
Janssen Pharmaceutica N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica N.V. filed Critical Janssen Pharmaceutica N.V.
Publication of PL358886A1 publication Critical patent/PL358886A1/pl
Publication of PL201656B1 publication Critical patent/PL201656B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D411/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
PL358886A 2000-06-22 2001-06-13 Pochodna imidazolidyny lub pirymidyny i sposób jej otrzymywania oraz kompozycja farmaceutyczna PL201656B1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00202180 2000-06-22
PCT/EP2001/006749 WO2001098306A1 (en) 2000-06-22 2001-06-13 Compounds for treating impaired fundic relaxation

Publications (2)

Publication Number Publication Date
PL358886A1 true PL358886A1 (pl) 2004-08-23
PL201656B1 PL201656B1 (pl) 2009-04-30

Family

ID=8171674

Family Applications (1)

Application Number Title Priority Date Filing Date
PL358886A PL201656B1 (pl) 2000-06-22 2001-06-13 Pochodna imidazolidyny lub pirymidyny i sposób jej otrzymywania oraz kompozycja farmaceutyczna

Country Status (33)

Country Link
US (2) US7081453B2 (pl)
EP (1) EP1296987B1 (pl)
JP (1) JP4911860B2 (pl)
KR (1) KR100821107B1 (pl)
CN (2) CN100516066C (pl)
AR (1) AR032158A1 (pl)
AT (1) ATE312104T1 (pl)
AU (1) AU783292B2 (pl)
BG (1) BG65895B1 (pl)
BR (1) BR0111859B1 (pl)
CA (1) CA2410233C (pl)
CZ (1) CZ305005B6 (pl)
DE (1) DE60115647T2 (pl)
EA (1) EA005760B1 (pl)
EE (1) EE04878B1 (pl)
EG (1) EG24462A (pl)
ES (1) ES2254467T3 (pl)
HR (1) HRP20020988B1 (pl)
HU (1) HU227398B1 (pl)
IL (2) IL153559A0 (pl)
IS (1) IS2618B (pl)
JO (1) JO2352B1 (pl)
MX (1) MXPA02012844A (pl)
MY (1) MY155267A (pl)
NO (1) NO328547B1 (pl)
NZ (1) NZ522519A (pl)
PA (1) PA8519601A1 (pl)
PL (1) PL201656B1 (pl)
SA (1) SA01220442B1 (pl)
SK (1) SK287730B6 (pl)
UA (1) UA74576C2 (pl)
WO (1) WO2001098306A1 (pl)
ZA (1) ZA200210303B (pl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU773773B2 (en) 1999-06-02 2004-06-03 Janssen Pharmaceutica N.V. Aminoalkyl substituted (benzodioxan, benzofuran or benzopyran) derivatives
PL198532B1 (pl) 1999-06-02 2008-06-30 Janssen Pharmaceutica Nv Pochodna benzopiranu podstawiona pirolidynylem, piperydynylem lub homopiperydynylem i sposób jej otrzymywania oraz kompozycja farmaceutyczna i sposób jej otrzymywania
JO2352B1 (en) * 2000-06-22 2006-12-12 جانسين فارماسيوتيكا ان. في Compounds for the treatment of non-adaptation of the bottom of the uterus
JO2654B1 (en) * 2000-09-04 2012-06-17 شركة جانسين فارماسوتيكا ان. في Multiple aryl caroxa amides are useful as lipid - lowering agents
JO2409B1 (en) 2000-11-21 2007-06-17 شركة جانسين فارماسوتيكا ان. في Second-phenyl carboxy amides are useful as lipid-lowering agents
PL1622569T3 (pl) 2003-04-24 2016-06-30 Incyte Holdings Corp Pochodne aza spiro alkanów jako inhibitory metaloproteaz
JP4896476B2 (ja) * 2005-09-16 2012-03-14 広栄化学工業株式会社 メチルオキシメチルアミノピリジン誘導体及びその製造方法
US7999107B2 (en) 2007-01-31 2011-08-16 Merck Sharp & Dohme Corp. Substituted pyrano[2,3-B]pyridine derivatives as cannabinoid-1 receptor modulators
CN101686983A (zh) * 2007-05-10 2010-03-31 Amr科技公司 芳基和杂芳基取代的四氢苯并-1,4-二氮杂䓬及其阻断去甲肾上腺素、多巴胺和5-羟色胺重摄取的用途
BR112014011254A2 (pt) 2011-11-11 2017-05-16 Pfizer 2-tiopirimidinonas
CR20170498A (es) 2015-05-05 2018-01-26 Pfizer 2-tiopirimidinonas
CN105481839B (zh) * 2015-11-23 2018-05-11 安徽千和新材料科技发展有限公司 一种光活性环氧啉对映体的制备方法
EP3229193A1 (en) 2016-04-07 2017-10-11 The Boeing Company A computer-implemented method and system for sharing information between passengers and air traffic management stakeholders

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3910930A (en) 1973-01-04 1975-10-07 Janssen Pharmaceutica Nv 1-{55 1-{8 2-(1,4-Benzodioxan-2-yl)-2-hydroxyethyl{9 -4-piperidyl{56 -2-benzimidazolinones
DE2400049A1 (de) * 1974-01-02 1975-07-10 Spumalit Anstalt Transportkasten aus kunststoff, insbesondere fuer flaschen
GR71865B (pl) * 1978-03-20 1983-07-07 Ciba Geigy
US4329348A (en) * 1979-02-26 1982-05-11 Ciba-Geigy Corporation N-Oxacyclic-alkylpiperidines as psychostimulants
EP0144101B1 (en) * 1983-11-30 1991-02-06 Janssen Pharmaceutica N.V. Bicyclic heterocyclyl containing n-(bicyclic heterocyclyl)-4-piperidinamines
SI9300097B (en) * 1992-02-27 2001-12-31 Janssen Pharmaceutica Nv (benzodioxan, benzofuran or benzopyran) alkylamino) alkyl substituted guanidines
ZA931343B (en) 1992-03-06 1993-09-24 Akzo Nv 1,4-dioxino(2,3-b)pyridine derivatives.
US6403103B1 (en) * 1994-08-12 2002-06-11 Bio Merieux Trypanosoma cruzi antigen, gene encoding therefore, and methods of detecting and treating chagas disease
FR2744451B1 (fr) * 1996-02-01 1998-04-24 Pf Medicament Nouvelles imidazolidinones, pyrimidinones, et 1,3-diazepin-2 -ones, leur preparation et leurs applications en therapeutique
US6133277A (en) * 1997-12-05 2000-10-17 Janssen Pharmaceutica N.V. (Benzodioxan, benzofuran or benzopyran) derivatives having fundic relaxation properties
AU773773B2 (en) * 1999-06-02 2004-06-03 Janssen Pharmaceutica N.V. Aminoalkyl substituted (benzodioxan, benzofuran or benzopyran) derivatives
PL198532B1 (pl) * 1999-06-02 2008-06-30 Janssen Pharmaceutica Nv Pochodna benzopiranu podstawiona pirolidynylem, piperydynylem lub homopiperydynylem i sposób jej otrzymywania oraz kompozycja farmaceutyczna i sposób jej otrzymywania
TWI225488B (en) * 1999-12-21 2004-12-21 Janssen Pharmaceutica Nv Derivatives of homopiperidinyl substituted benzimidazole analogues
JO2352B1 (en) * 2000-06-22 2006-12-12 جانسين فارماسيوتيكا ان. في Compounds for the treatment of non-adaptation of the bottom of the uterus

Also Published As

Publication number Publication date
CA2410233A1 (en) 2001-12-27
BG107313A (bg) 2003-06-30
WO2001098306A1 (en) 2001-12-27
HK1057896A1 (en) 2004-04-23
EE200200694A (et) 2004-06-15
DE60115647D1 (de) 2006-01-12
ATE312104T1 (de) 2005-12-15
JP4911860B2 (ja) 2012-04-04
MY155267A (en) 2015-09-30
AU8386401A (en) 2002-01-02
HUP0301185A3 (en) 2009-03-30
IS6591A (is) 2002-10-25
SK287730B6 (en) 2011-07-06
HRP20020988B1 (en) 2011-06-30
US7423048B2 (en) 2008-09-09
CZ305005B6 (cs) 2015-03-25
EE04878B1 (et) 2007-08-15
HUP0301185A2 (hu) 2003-08-28
HU227398B1 (hu) 2011-05-30
NZ522519A (en) 2003-09-26
PA8519601A1 (es) 2002-08-26
CN1288157C (zh) 2006-12-06
DE60115647T2 (de) 2006-08-24
BG65895B1 (bg) 2010-04-30
NO20026219D0 (no) 2002-12-23
MXPA02012844A (es) 2003-05-15
CN1437602A (zh) 2003-08-20
AU783292B2 (en) 2005-10-13
CA2410233C (en) 2011-01-25
SK492003A3 (en) 2003-07-01
CZ2003115A3 (cs) 2003-06-18
KR20030007566A (ko) 2003-01-23
NO328547B1 (no) 2010-03-15
US20040019051A1 (en) 2004-01-29
EP1296987A1 (en) 2003-04-02
UA74576C2 (en) 2006-01-16
BR0111859A (pt) 2003-05-13
JP2004501157A (ja) 2004-01-15
US7081453B2 (en) 2006-07-25
JO2352B1 (en) 2006-12-12
HRP20020988A2 (en) 2005-02-28
EG24462A (en) 2009-07-16
EA005760B1 (ru) 2005-06-30
ES2254467T3 (es) 2006-06-16
KR100821107B1 (ko) 2008-04-14
EA200300049A1 (ru) 2003-04-24
IS2618B (is) 2010-04-15
BR0111859B1 (pt) 2015-01-06
AR032158A1 (es) 2003-10-29
NO20026219L (no) 2003-02-17
SA01220442B1 (ar) 2008-05-21
PL201656B1 (pl) 2009-04-30
EP1296987B1 (en) 2005-12-07
CN100516066C (zh) 2009-07-22
ZA200210303B (en) 2004-03-19
CN1781921A (zh) 2006-06-07
IL153559A (en) 2008-03-20
US20060142318A1 (en) 2006-06-29
IL153559A0 (en) 2003-07-06

Similar Documents

Publication Publication Date Title
WO1999029687A8 (en) (benzodioxan, benzofuran or benzopyran) derivatives having fundic relaxation properties
PL358886A1 (pl) Związki do leczenia upośledzonego wiotczenia dna żołądka
PL363380A1 (pl) 1,5-Benzotiazepiny i ich zastosowanie jako środków przeciwhiperlipidemicznych
UA121036C2 (uk) 2-(морфолін-4-іл)-1,7-нафтиридини
GB0121337D0 (en) Chemical compounds
GB0121622D0 (en) Chemical compounds
MY117803A (en) Monocyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives
PL358281A1 (pl) Nowe związki
GB9813540D0 (en) Chemical compounds
SE0000772D0 (sv) Chemical compounds
IS7170A (is) Bensóþíasepín og bensóþíadíasepínafleiður með tálmavirkni gegn dausgarnargallsýruflutningi (ileal bile acid transport, IBAT) til að meðhöndla fitudreyra
MY119118A (en) Thiophenopyrimidines
CN101534829A (zh) 丙型肝炎病毒抑制剂
GB0121621D0 (en) Chemical compounds
MY114926A (en) N-heteroaryl-pyridinesulfonamide derivatives and their use as endothelin antagonists
MXPA00006605A (es) Compuestos de carbonil-indol biciclicos como agentes antiinflamatorios/analgesicos.
MY121852A (en) 4-(aminoethyl)-piperidine benzamides for treating gastrointestinal disorders
IL162614A0 (en) Liposomal delivery of vitamin e based compounds
ZA200103106B (en) Bile-acid substituted phenyl alkenoyl guanidines, method for the production thereof, use thereof as medicaments or diagnostic agents and medicaments that contain them.
CZ301048B6 (cs) Deriváty streptograminu, zpusob jejich prípravy a kompozice, které je obsahují
GB0117396D0 (en) Chemical compounds
MXPA04003479A (es) Novedosos derivados de 4-fenil-4[1h-imidazol-2-il]piperidina sustituida y su uso como agonistas selectivos no peptidicos de opiodes delta.
GB0120461D0 (en) Novel compounds
BG106157A (en) Pyrrolidinyl, piperidinyl or homopiperidinyl substituted (benzodioxan, benzofuran or benzopyran) derivatives
BG106156A (en) Aminoalkyl substituted (benzodioxan, benzofuran or benzopyran) derivatives